Relationship between the expression of PD-1/PD-L1 and 18F-FDG uptake in bladder cancer

被引：0
|
作者：
Ruohua Chen
Xiang Zhou
Jianjun Liu
Gang Huang
机构：
[1] Shanghai Jiao Tong University,Department of Nuclear Medicine, Ren Ji Hospital, School of Medicine
[2] Shanghai University of Medicine & Health Sciences,undefined
来源：
European Journal of Nuclear Medicine and Molecular Imaging | 2019年 / 46卷
关键词：
Bladder cancer; PD-1; PD-L1; PET/CT; SUVmax;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：848 / 854
页数：6
相关论文
共 50 条
  • [41] The Value of 18F-FDG PET/CT in Predicting the Response to PD-1 Blocking Immunotherapy in Advanced NSCLC Patients with High-Level PD-L1 Expression
    Vekens, Karolien
    Everaert, Hendrik
    Neyns, Bart
    Ilsen, Bart
    Decoster, Lore
    CLINICAL LUNG CANCER, 2021, 22 (05) : 432 - 440
  • [42] PD-1/PD-L1 Axis in Lung Cancer
    Santini, Fernando C.
    Hellmann, Matthew D.
    CANCER JOURNAL, 2018, 24 (01): : 15 - 19
  • [43] Relationship between the ultrasound features of different molecular subtypes of breast cancer and positive PD-1/PD-L1 expression
    Yan, Ruiqian
    Li, Haixia
    Gao, Junxi
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2025, 53 (02)
  • [44] Expression of Immunomodulatory Molecules PD-1, PD-L1, and PD-L2, and their Relationship With Clinicopathologic Characteristics in Endometrial Cancer
    Sungu, Nuran
    Yildirim, Melahat
    Desdicioglu, Raziye
    Aydogdu, Ozge Basaran
    Kilicarslan, Aydan
    Dogan, Hayriye Tatli
    Yazgan, Aylin Kilic
    Akyol, Mesut
    Erdogan, Fazli
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2019, 38 (05) : 404 - 413
  • [45] PD-1/PD-L1 Inhibitors in Cervical Cancer
    Liu, Yuncong
    Wu, Li
    Tong, Ruizhan
    Yang, Feiyue
    Yin, Limei
    Li, Mengqian
    You, Liting
    Xue, Jianxin
    Lu, You
    FRONTIERS IN PHARMACOLOGY, 2019, 10
  • [46] Antagonists of PD-1 and PD-L1 in Cancer Treatment
    Lipson, Evan J.
    Forde, Patrick M.
    Hammers, Hans-Berg
    Emens, Leisha A.
    Taube, Janis M.
    Topalian, Suzanne L.
    SEMINARS IN ONCOLOGY, 2015, 42 (04) : 587 - 600
  • [47] PD-1/PD-L1 Pathway in Breast Cancer
    Schuetz, Florian
    Stefanovic, Stefan
    Mayer, Luisa
    von Au, Alexandra
    Domschke, Christoph
    Sohn, Christof
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 (05) : 294 - 297
  • [48] PD-1/PD-L1 and immunotherapy for pancreatic cancer
    Feng, Mengyu
    Xiong, Guangbing
    Cao, Zhe
    Yang, Gang
    Zheng, Suli
    Song, Xujun
    You, Lei
    Zheng, Lianfang
    Zhang, Taiping
    Zhao, Yupei
    CANCER LETTERS, 2017, 407 : 57 - 65
  • [49] PD-L1 expression correlation with metabolic parameters of 18F-FDG PET/CT in nonsmall cell lung cancer
    Akgun, E.
    Akyel, R.
    Koc, A. S.
    Demirkol, B.
    Kabalak, P. A.
    Ozmen, O.
    Baydili, K. N.
    Batur, S.
    Oz, A. B.
    Yilmaz, U.
    Demirag, F.
    Akyurek, N.
    Cetinkaya, E.
    MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE, 2024, 48 (01): : 23 - 32
  • [50] PD-1 and PD-L1 Expression in Endometrial Cancer: A Systematic Review of the Literature
    Tommasi, Orazio De
    Marchetti, Matteo
    Tripepi, Marta
    Bigardi, Sofia
    Incognito, Giosue Giordano
    Tuninetti, Valentina
    Facchetti, Emma
    Tasca, Giulia
    Noventa, Marco
    Saccardi, Carlo
    Tozzi, Roberto
    Spagnol, Giulia
    JOURNAL OF CLINICAL MEDICINE, 2025, 14 (02)
12345